Vilimed
PrivateLast Round
Grant
Nov 16, 2025
Total Funding Raised
$320,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vilimed operates in Healthcare & Life Sciences and is based in Kaunas. Its latest recorded funding round was a Seed round in December 2022.
Vilimed is a health tech company that develops and commercializes non-invasive medical devices, including the VILIM ball, for hand tremor reduction in patients with Essential Tremor and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Patient Engagement
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vilimed Comparables
Compare Vilimed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GyroGear Ltd | 89% | |
| Encora Therapeutics | 86% | |
| Steadiwear | 86% |
For institutional investors. Book with your work email.
Vilimed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 16, 2025 | ||||
| Seed | Dec 29, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vilimed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LitBAN | Seed |
| Coinvest Capital | Seed |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Monthly visitors increased 89% MoM.
- Feb 14, 2026
Grew 50% QoQ, from 8 to 12 employees.
For institutional investors. Book with your work email.
Vilimed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vilimed's valuation, stock price, and market status.
Is Vilimed a public or private company?
Vilimed is a private company.
What is the current stock price of Vilimed?
Vilimed is a private company, so its shares have no public market price. Caplight tracks Vilimed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vilimed worth (valuation)?
Valuation information for Vilimed is not publicly available.
Can I buy Vilimed stock?
Vilimed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vilimed's last funding round?
Vilimed's most recent funding round was Grant on November 16, 2025.
Who are the main investors in Vilimed?
Key investors in Vilimed include Coinvest Capital.
Will Vilimed IPO soon?
No public IPO plans have been announced for Vilimed.
How can I track Vilimed secondary market activity?
Caplight tracks bids, offers, and trades in Vilimed's shares on secondary markets.